Radiomics and Radiogenomics of Non-small Cell Lung Cancer
Conditions: Non Small Cell Lung Cancer Interventions: Diagnostic Test: Radiomic signature Sponsors: European Institute of Oncology Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials
DC Combined With ICIs in the Treatment of Advanced Lung Cancer Resistant to ICIs
Conditions: Lung Cancer Interventions: Drug: LG002 Sponsors: Zhen-Yu Ding Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials
A Study to Learn About How BAY2927088 Affects the Level of Dabigatran or Rosuvastatin in the Blood When These Drugs Are Taken Together in Healthy Participants
Conditions: Advanced Non-small Cell Lung Cancer; EGFR Mutation; HER2 Mutation; Healthy Volunteers Interventions: Drug: BAY2927088; Drug: Dabigatran etexilate; Drug: Rosuvastatin Sponsors: Bayer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials
Treatment of Pulmonary SUlcus, Pancoast and Chest Wall Non-small Cell Lung Cancer Employing Radiation, Immuno-oncology and Resection
Conditions: Lung Cancer Patients; Non-small Cell Lung Cancer (NSCLC) Interventions: Drug: Durvalumab; Radiation: Non-ablative oligofractionated radiation (NORT) Sponsors: Marc de Perrot; Ozmosis Research Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials
A Single-arm Pilot Study of First-line Treatment With Carbognilumab Combined With Chemotherapy in Patients With STK11-mutated Advanced or Postoperative Recurrent Non-small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer Interventions: Drug: cadonilimab Sponsors: Guangzhou Institute of Respiratory Disease Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials
Anesthesia and Non-small Cell Lung Cancer Recurrence
Conditions: Non-small Cell Lung Cancer; Surgery; Anesthesia Interventions: Drug: Propofol; Drug: Inhaled anesthetics Sponsors: Samsung Medical Center; Seoul National University Hospital; Asan Medical Center; Severance Hospital; Seoul St. Mary ' s Hospital; Korea University Guro Hospital; DongGuk University; Inha University Hospital; Konkuk University Medical Center; Ewha Womans University; Chungnam National University Hospital; University of Virginia; Memorial Sloan Kettering Cancer Center; Yale University; Mayo Clinic; University of Texas Southwestern Medical Center; University Hospitals Coventry and Warwickshire NHS Trus...
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials
Assessment System of Sarcopenia in Lung Cancer Patients
Conditions: Sarcopenia; Lung Cancer; Ultrasound Interventions: Diagnostic Test: ultrasound scan; Diagnostic Test: CT/MRI scan Sponsors: West China Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2024 Category: Research Source Type: clinical trials
Lung Cancer Risk Assessment and Etiology
Conditions: Lung Carcinoma Interventions: Procedure: Biospecimen Collection; Procedure: Computed Tomography; Other: Electronic Health Record Review; Other: Survey Administration Sponsors: City of Hope Medical Center; National Cancer Institute (NCI) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2024 Category: Research Source Type: clinical trials
Testing the Engaged Approach to Lung Cancer Screening
Conditions: Lung Cancer Interventions: Behavioral: Engaged Approach to Lung Cancer Screening Sponsors: University of Colorado, Denver; Bristol-Myers Squibb Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2024 Category: Research Source Type: clinical trials
Reducing Chronic Breathlessness in Adults by Following a Self-guided, Internet Based Supportive Intervention (SELF-BREATHE)
Conditions: Advanced Respiratory Disease; Chronic Breathlessness Due to Advanced Respiratory Disease; Chronic Obstructive Pulmonary Disease; Bronchiectasis; Interstitial Lung Disease; Lung Cancer; Asthma; Chronic Fibrotic Lung Disease Following SARS-CoV2 Infection Interventions: Other: SELF-BREATHE Sponsors: King ' s College Hospital NHS Trust Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
Differences in Rate of Decline in CT-defined Skeletal Muscle Mass and Physical Performance in Patients With Advanced Non-small Cell Lung Cancer Receiving Chemotherapy and Targeted Therapy/Immunotherapy, Before and After Treatment.
Conditions: Advanced Lung Cancer; Sarcopenia Interventions: Drug: Chemotherapy drug; Drug: Targeted Agent; Drug: Immunotherapy Sponsors: Prince of Songkla University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
Adjuvant Target Therapy Guided by ctDNA-MRD in Patients With EGFR-mutant II-IIIA Non-small Cell Lung Cancer (ECTOP-1022)
Conditions: Lung Cancer; EGFR Gene Mutation; Minimal Residual Disease Interventions: Drug: Osimertinib; Drug: No adjuvant therapy Sponsors: Fudan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2024 Category: Research Source Type: clinical trials
Evaluating the Impact of Centralized Interventions on Lung Cancer Screening Adherence in Community Settings, ACCELL Trial
Conditions: Lung Carcinoma Interventions: Other: Electronic Health Record Review; Other: Interview; Behavioral: Patient Navigation Sponsors: Fred Hutchinson Cancer Center; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2024 Category: Research Source Type: clinical trials
A Real-world Study of Adebrelimab Combined With Chemotherapy ±Chest Radiotherapy in Patients With Extensive Stage Small Cell Lung Cancer
Conditions: Extensive Stage Small Cell Lung Cancer Interventions: Drug: Adebrelimab + chemotherapy; Radiation: ±chest radiotherapy Sponsors: Hebei Medical University Fourth Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2024 Category: Research Source Type: clinical trials
High-dose Furmonertinib Versus Osimertinib in Advanced EGFRm NSCLC Patients With Brain Metastases
Conditions: Lung Cancer, Nonsmall Cell Interventions: Drug: Furmonertinib; Drug: Osimertinib Sponsors: Taizhou Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
